Current data has a 15-minute delay. Please Sign Up /
Sign In to get real-time quotes.
stocks
/
NASDAQ-INKT
/
I
MiNK Therapeutics
INKT
INKTMiNK TherapeuticsNASDAQ
Add to watchlist
0.9019
0.0149(+1.68 %)
At close :
Jan 06, 16:00 ET
0.8604
-0.0415(-4.60 %)
Post market
19:15 ET
I
MiNK Therapeutics
INKT
(INKT)
0.9019
0.0149(+1.68 %)
Summary
Options
Financials
News
Filings
Profile
INKT Chart
See on advanced chart >
...
All
...
D
...
W
...
M
...
5m
...
Volume354.33k
Turnover82.84M
P/E(TTM)27.37
Turnover %0.98%
P/E(Static)28.51
Market Cap8.44B
P/B4.62
Shares36.27M
52 Week Range
159.69
278.38
Day Range
231.86
240.51
About
MiNK Therapeutics, Inc. was incorporated in Delaware in July 2017. The company is a clinical stage biopharmaceutical company pioneering the discovery, development and commercialization of allogeneic, off-the-shelf iNKT cell therapies to treat cancer and other...
Read More
Highlight
A biotechnology company focused on developing cancer immunotherapies and autoimmune disease treatments